These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 544156)
21. The obese patient. Bray GA Major Probl Intern Med; 1976; 9():1-450. PubMed ID: 778504 [No Abstract] [Full Text] [Related]
22. [Prevention of sequelae following obesity by prolonged weight reducing diets]. Aszódi Z Orv Hetil; 1965 Sep; 106(36):1686-91. PubMed ID: 5825294 [No Abstract] [Full Text] [Related]
23. [On some metabolic and therapeutic aspects of obesity. Reports of cases treated with phenproporex]. De Lorenzi F; Costa C; Fetta RF; Fresco G Arch Maragliano Patol Clin; 1969; 25(2):149-75. PubMed ID: 5819382 [No Abstract] [Full Text] [Related]
24. [Therapy of obesity]. Berger M; Berchtold P; Krüskemper GM; Zimmermann H Internist (Berl); 1976 Oct; 17(10):494-501. PubMed ID: 791885 [No Abstract] [Full Text] [Related]
25. [Tolerance and acceptability of dexfenfluramine in the long-term treatment of obesity in private practice. ESIM Group]. Héraïef E Rev Med Suisse Romande; 1997 Jan; 117(1):19-24. PubMed ID: 9082531 [TBL] [Abstract][Full Text] [Related]
26. [Phentermine resinate in obesity. Clinical trial of Mirapront in adipose children]. Spranger J Munch Med Wochenschr; 1965 Sep; 107(38):1833-4. PubMed ID: 5323498 [No Abstract] [Full Text] [Related]
27. [Drugs and obesity: current status, prospects for the future]. Apfelbaum M Rev Prat; 1984 Dec; 34(55):3121-4. PubMed ID: 6505592 [No Abstract] [Full Text] [Related]
28. [The treatment of obesity: diet, drugs and surgery]. Ducobu J Rev Med Brux; 1994; 15(4):262-6. PubMed ID: 7939000 [No Abstract] [Full Text] [Related]
29. [Therapy of obesity and fat metabolism disorders]. Teubner W Z Allgemeinmed; 1970 Jun; 46(18):911-6. PubMed ID: 5509307 [No Abstract] [Full Text] [Related]
30. [Struggle about the best reducing diet, Fat gone by means of more fat?]. Bischoff A MMW Fortschr Med; 2004 Jan; 146(1-2):4-6. PubMed ID: 18441569 [No Abstract] [Full Text] [Related]
32. A double-blind evaluation of an anorexiant, a placebo and diet alone in obese subjects. Resnick M; Joubert L Can Med Assoc J; 1967 Oct; 97(17):1011-5. PubMed ID: 6052899 [No Abstract] [Full Text] [Related]
33. [Are thyroid gland preparations indicated in the treatment of obesity?]. Dolecek R Vnitr Lek; 1968 Aug; 14(8):775-91. PubMed ID: 5683106 [No Abstract] [Full Text] [Related]
34. [Comparison of results of short- and long-term therapy of obesity]. Romiti A; Salandri A; Buzzetti R; Festuccia F; Giovannini C Clin Ter; 1997 Apr; 148(4):159-64. PubMed ID: 9377850 [TBL] [Abstract][Full Text] [Related]
35. [The long-term results of low-calorie diet therapy in the obese]. Festuccia F; Salandri A; Labonia A; Ferraro A; Romiti A; Giovannini C Clin Ter; 1998; 149(3):197-202. PubMed ID: 9842102 [TBL] [Abstract][Full Text] [Related]
36. [The treatment of obesity with the appetite curbing agent Mefenorex]. Beyer G; Huth K; Müller GM; Niemöller H; Raisp I; Vorberg G Med Welt; 1980 Feb; 31(8):306-9. PubMed ID: 7374423 [No Abstract] [Full Text] [Related]
37. [Treatment of obesity (author's transl)]. Hartmann G Schweiz Rundsch Med Prax; 1974 Oct; 63(9):1169-71. PubMed ID: 4411349 [No Abstract] [Full Text] [Related]
38. [Contribution to a study of a new lipolytic and anorectic drug: fenproporex (author's transl)]. Nájera Mortes J Folia Clin Int (Barc); 1973 Feb; 23(2):134-51. PubMed ID: 4804960 [No Abstract] [Full Text] [Related]
39. The effect of 1-yr sibutramine treatment on glucose tolerance, insulin sensitivity and serum lipid profiles in obese subjects. Sabuncu T; Ucar E; Birden F; Yasar O Diabetes Nutr Metab; 2004 Apr; 17(2):103-7. PubMed ID: 15244102 [TBL] [Abstract][Full Text] [Related]